Professional
Added to YB: 2026-01-26
Pitch date: 2026-01-15
EW [neutral]
Edwards Lifesciences Corporation
-6.24%
current return
Author Info
No bio for this author
Company Info
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Market Cap
$44.0B
Pitch Price
$84.17
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.86
P/E
41.92
EV/Sales
6.74
Sector
Health Care Equipment and Supplies
Category
growth
Wedgewood Partners Portfolio Holding: Edwards Lifesciences Corporation
EW (holding update): Favorable 7-year data for transcatheter aortic valves while competitors exit key markets. Long-term data evolving care standards, making minimally invasive alternatives preferred over open heart surgery. Positioned for double-digit earnings growth next few years.
Read full article (1 min)